Terminalcare Support Institute Inc.
Fiscal Year Ending December 2026 Q3 Earnings Presentation
Significant year-over-year profit increase. Revenue reached 4,354 million yen and EBITDA surged to 284 million yen. Full-year guidance is unchanged while accounting for one-time Q4 expenses. Expansion of the elderly-care business and internal development of CareMaster/BillMaster boosted profitability, and growth is expected to continue into the next fiscal year.
Key Figures
- Revenue: 4,354 million yen
- EBITDA: 284 million yen
- Ordinary Income: 172 million yen
AI要約
Performance Overview
In Q3, revenue increased significantly year-over-year, and key indicators including EBITDA, ordinary income and net income improved substantially. Steady rollout of new locations and advancement of in-house developed systems have driven the shift to profitability and growth. Certain expenses are expected in Q4, so the full-year forecast remains unchanged.
Implications for Investors and Outlook
Expansion of the elderly-care business and internalization of systems have improved cost-effectiveness. The in-house development of CareMaster/BillMaster is expected to contribute to long-term profitability. From the next fiscal year onward, the new opening strategy will shift to a "replacement model" to balance financial soundness and growth.
Comparison of Forecast and Actuals
Terminalcare Support Institute Inc.
Company overview · Stock price · Financial data · All IR
